Co-production of blaNDM-1 and blaOXA-23 in multiresistant clinical isolates of Acinetobacter baumannii from Brazil

Authors

DOI:

https://doi.org/10.33448/rsd-v11i9.31253

Keywords:

Acinetobacter baumannii; blaNDM-1 ; blaOXA-23.

Abstract

Acinetobacter baumannii is a common and dangerous non-fermenting gram-negative bacillus due to its various and increasing resistance mechanisms. Therefore, the objective of the work was to describe four NDM-1 -producing Acinetobacter isolates from Natal, northeastern Brazil. These four isolates were identified as Acinetobacter baumannii by MALDI-TOF. All isolates were characterized by antimicrobial susceptibility testing, with resistance to all β-lactams including carbapenems and positive for the synergy test with Ethylenediaminetetraacetic acid. PCR analysis was also performed for blaNDM-1, blaVIM-1, blaIMP-1, blaOXA-23, blaOXA-24/40, blaOXA-51, blaOXA-58, and blaOXA-143 genes and showed positive for the blaNDM-1 and blaOXA-23 genes in all isolates and this result was confirmed by sequencing. This is the first case of Acinetobacter baumannii strains harboring blaNDM-1 gene isolated from northeastern Brazil. This description emphasizes the need for new prevention and control strategies of the dissemination of NDM-1-producing Acinetobacter, which are associated with a high mortality rate.

References

Adams, M. D., Pasteran, F., Traglia, G. M., Martinez, J., Huang, F., et al. (2020). Distinct mechanisms of dissemination of NDM-1 metallo-β-lactamase in Acinetobacter species in Argentina. Antimicrobial agents and chemotherapy, 64(5), e00324-20. 10.1128/AAC.00324-20.

Bonnin, R. A., Poirel, L., & Nordmann, P. (2014). New Delhi metallo-β-lactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes. Future microbiology, 9(1), 33-41. 10.2217/fmb.13.69.

Chatterjee, S., Datta, S., Roy, S., Ramanan, L., Saha, A., et al. (2016). Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to ISAba125. Frontiers in microbiology, 7, 1126. 10.3389/fmicb.2016.01126.

CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and laboratotry Standard Institute; 2015.

Dortet, L., Nordmann, P., & Poirel, L. (2012). Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 56(4), 1693-1697. 10.1128/AAC.05583-11.

FDA, “FDA-Identified Interpretive Criteria,” Tigecycline – Injection products, 2017. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm587585.htm.

Fernández-Cuenca, F., Pérez-Palacios, P., Galán-Sánchez, F., López-Cerero, L., López-Hernández, I., et al. First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain. Enfermedades infecciosas y microbiologia clinica (English ed.), 38(1), 11-15. 10.1016/j.eimce.2019.03.013.

Furlan, J. P. R., Pitondo-Silva, A., & Stehling, E. G. (2018). Detection of bla NDM-1 in Stenotrophomonas maltophilia isolated from Brazilian soil. Memórias do Instituto Oswaldo Cruz, 113. 10.1590/0074-02760170558.

Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005). Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 49(8), 3198-3202. 10.1128/AAC.49.8.3198.

Higgins, P. G., Poirel, L., Lehmann, M., Nordmann, P., & Seifert, H. (2009). OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 53(12), 5035-5038. 10.1128/AAC.00856-09.

Joshi, P. R., Acharya, M., Kakshapati, T., Leungtongkam, U., Thummeepak, R., & Sitthisak, S. (2017). Co-existence of bla OXA-23 and bla NDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrobial Resistance & Infection Control, 6(1), 1-7. 10.1186/s13756-017-0180-5.

Khan, A. U., Maryam, L., & Zarrilli, R. (2017). Structure, genetics and worldwide spread of New Delhi metallo-β-lactamase (NDM): a threat to public health. BMC microbiology, 17(1), 1-12. 10.1186/s12866-017-1012-8.

Kumari, M., Verma, S., Venkatesh, V., Gupta, P., Tripathi, P., et al. (2021). Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India. Plos one, 16(9), e0256308. 10.1371/journal.pone.0256308.

Pagano, M., Poirel, L., Martins, A. F., Rozales, F. P., Zavascki, A. P., Barth, A. L., & Nordmann, P. (2015). Emergence of NDM-1-producing Acinetobacter pittii in Brazil. International journal of antimicrobial agents, 45(4), 444-445. 10.1016/j.ijantimicag.2014.12.011.

Pasteran, F., Mora, M. M., Albornoz, E., Faccone, D., Franco, R., et al. (2014). Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay. Journal of Antimicrobial Chemotherapy, 69(9), 2575-2578. 10.1093/jac/dku139.

Pillonetto, M., Arend, L., Vespero, E. C., Pelisson, M., Chagas, T. P. G., Carvalho-Assef, A. P. D. A., & Asensi, M. D. (2014). First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil. Antimicrobial agents and chemotherapy, 58(12), 7592-7594. 10.1128/AAC.03444-14.

Poirel, L., Naas, T., & Nordmann, P. (2010). Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrobial agents and chemotherapy, 54(1), 24-38. 10.1128/AAC.01512-08.

Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011). Multiplex PCR for detection of acquired carbapenemase genes. Diagnostic microbiology and infectious disease, 70(1), 119-123. 10.1016/j.diagmicrobio.2010.12.002.

Rozales, F. P., Ribeiro, V. B., Magagnin, C. M., Pagano, M., Lutz, L., Falci, D. R., & Zavascki, A. P. (2014). Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. International Journal of Infectious Diseases, 25, 79-81.10.1016/j.ijid.2014.01.005.

Tran, D. N., Tran, H. H., Matsui, M., Suzuki, M., Suzuki, S., et al. (2017). Emergence of New Delhi metallo-beta-lactamase 1 and other carbapenemase-producing Acinetobacter calcoaceticus-baumannii complex among patients in hospitals in Ha Noi, Viet Nam. European Journal of Clinical Microbiology & Infectious Diseases, 36(2), 219-225. 10.1007/s10096-016-2784-8.

Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. International journal of antimicrobial agents, 27(4), 351-353. 10.1016/j.ijantimicag.2006.01.004.

Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009). Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial agents and chemotherapy, 53(12), 5046-5054. 10.1128/AAC.00774-09.

Zenati, K., Touati, A., Bakour, S., Sahli, F., & Rolain, J. M. (2016). Characterization of NDM-1-and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria. Journal of Hospital Infection, 92(1), 19-26. 10.1016/j.jhin.2015.09.020.

Zhang, C., Qiu, S., Wang, Y., Qi, L., Hao, R., et al. (2013). Higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals in Beijing. PloS one, 8(6), e64857. 10.1371/journal.pone.0064857.

Zhang, R., Hu, Y. Y., Yang, X. F., Gu, D. X., Zhou, H. W., Hu, Q. F., & Chen, G. X. (2014). Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China. European journal of clinical microbiology & infectious diseases, 33(5), 853-860. 10.1007/s10096-013-2024-4.

Downloads

Published

03/07/2022

How to Cite

LOPES, M. C. S.; ÉVORA , B. H. S. R. .; OLIVEIRA , C. B. S. de .; OLIVEIRA, E. S. de; MELO, M. C. N. de . Co-production of blaNDM-1 and blaOXA-23 in multiresistant clinical isolates of Acinetobacter baumannii from Brazil. Research, Society and Development, [S. l.], v. 11, n. 9, p. e6511931253, 2022. DOI: 10.33448/rsd-v11i9.31253. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/31253. Acesso em: 13 aug. 2022.

Issue

Section

Health Sciences